ArticleBritish journal of haematology2025
Service evaluation of R90 bleeding and platelet disorders gene panel in thrombocytopenia cases.
Article in British journal of haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Determinants of thrombocytopenia in critically ill patients: a systematic review and meta-analysis.Frontiers in medicine · 2026Pooled it
- Can machine learning identify inherited causes of thrombocytopenia? A feasibility study.British journal of haematology · 2026Article
- Service evaluation of R90 bleeding and platelet disorders gene panel in thrombocytopenia cases.British journal of haematology · 2025Article
- The diagnostic utility of genetic testing in inherited thrombocytopenia: regional multicenter tertiary experience.Research and practice in thrombosis and haemostasis · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study examines the R90 bleeding and platelet disorders gene panel's utility in thrombocytopenia. The study analysed the correlations between the clinical features of patients with thrombocytopenia and genetic outcomes. The diagnostic yield was 46.6% (41/88) for the overall panel for all patients referred locally. Thrombocytopenia >12 months (95% CI = 19.0-191.0, p < 0.01), having a first-degree relative with thrombocytopenia (16 vs. 7, p < 0.01) and a higher platelet count nadir (67.9 ± 35.0 vs. 39.4 ± 33.9 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.